ZP
STSA

Zimmer Partners’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

Zimmer Partners’s Portfolio STSA Stock Details STSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-100,000
Closed -$1.97M – 110
2019
Q4 		$1.97M Hold
100,000
– – 0.03% 69
2019
Q3 		$1.5M Buy
+100,000
New +$1.55M 0.02% 90

Other funds holding STSA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Zimmer Partners's STSA Position: Q1 2020 in Review

Zimmer Partners sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q1 2020, closing a stake of 100,000 shares — an estimated $1.97M sold.

Zimmer Partners first reported a position in STSA in Q3 2019 and held it in 2 quarters. The position peaked at $1.97M in Q4 2019. 36 funds tracked by Wall St. Rank hold STSA as of Q1 2020.

  • Zimmer Partners reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Zimmer Partners sold 100,000 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q1 2020, an estimated $1.97M.
  • Zimmer Partners first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 2 quarters.
  • Zimmer Partners's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $1.97M in Q4 2019.
  • 36 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q1 2020.

Based on Zimmer Partners's 13F filing for Q1 2020, filed 15 May 2020.